Skip to main content

Natural Patterns and Magnetic and Mental Processes of Coronavirus Activation and Neutralization- Crimson Publishers

Natural Patterns and Magnetic and Mental Processes of Coronavirus Activation and Neutralization- Crimson Publishers



For twenty years, humanity has seen the third attempt at the transition of coronavirus to humans. The vaccine has been found, but coronavirus transitions will not stop even with the improvement of medicine. Nobel laureate in medicine Professor Luc Montagnier argues that vaccines may not live up to humanity’s hopes of getting rid of COVID-19. Collective immunity for coronavirus has not been developed, repeated infections are more and more common, beds of seriously ill people are not empty, and mortality is running high, no one knows what will happen to all of us. In Israel, where vaccination has long been compulsory, and over 60% of the population, including underage children, have been vaccinated, the incidence is not just declining, but still breaking all records. So, the maximum number of cases here was revealed on September 1 - 16,629, which almost caught up with Russia (18,368 confirmed on the same September 1) with our percentage of vaccinated 26.1% of the number of citizens. At the end of September 2021, morbidity and mortality increase, because it is a system. Based on existing monthly pneumonia mortality statistics over the past 15 years, there are three waves each year. Since September 22, there has been a surge of pneumonia, ARI, and even non-communicable diseases. The second wave comes at the end of December - January, it is usually three times larger than the first. Then around March-April there is a third wave. These three waves exist steadily from year to year, their amplitudes can change, then one will be higher, then the other, they are not absolutely hard on schedule, but they are reproduced regularly in other countries. The first wave of the Spanish pandemic covered the world just at the end of September 1918. The coronavirus was the same. The first wave in America is September 2019, an unexplained surge of pneumonia with a rather high mortality rate, which was written off for smoking e-cigarettes and called “vape.” Now they decided to watch the surviving tests of patients, and there - COVID-19. In Europe, it was the same.

https://crimsonpublishers.com/rmes/fulltext/RMES.000717.php

For more open access journals in crimson publishers Please click on link: https://crimsonpublishers.com

For more articles on Research in Medical & Engineering Sciences Please click on link: https://crimsonpublishers.com/rmes/

Labels:

Comments

Post a Comment

Popular posts from this blog

The Malachite Wen-Myeloid Sarcoma- Crimson Publishers

The Malachite Wen-Myeloid Sarcoma- Crimson Publishers   Contingent to World Health Organization (WHO) classification, myeloid sarcoma is denominated as a tumefaction comprised of myeloblasts amalgamated at an anatomical site divergent from the bone marrow which engenders distortion of normal tissue architecture. Generally, myeloid sarcoma is contemplated to be equivalent to and concurrent with acute myeloid leukaemia (AML), although lesions may occur in isolation. Additionally designated as granulocytic sarcoma, chloroma or extramedullary myeloid tumour, myeloid sarcoma categorically represents as a distinct tumefaction associated with architectural effacement of circumscribing soft tissue. Myeloid sarcoma may emerge as a de novo lesion or manifest as therapy related myeloid neoplasm or as disease progression within myeloproliferative neoplasm (MPN), myelodysplastic syndrome (MDS) or myelodysplastic / myeloproliferative neoplasm (MDS / MPN). In contrast, leukaemia cutis (LC) is...
Post a Comment
Read more

Recent Developments of Decentralized Clinical Trial Technology in Korea- Crimson Publishers

Recent Developments of Decentralized Clinical Trial Technology in Korea- CrimsonPublishers   Clinical trials are routinely performed on human participants to evaluate the safety and effectiveness of new treatments such as drugs and medical devices. Recent advances in Information and Communication Technology (ICT) have led to the development of Decentralized Clinical Trials (DCTs). DCTs allow participants to participate in various types of clinical trials without having to visit hospitals. Data collection and frequent interactions between participants and medical staff can be possible via remote monitoring environments. In addition, the costs and time for clinical trials conduction can be significantly reduced. The development of ICT-based DCT technologies has already initiated. However, the adoption of DCTs was facilitated by the coronavirus disease 2019 (COVID-19) pandemic. Interest in and research on DCTs has also grown in Korea. This study describes the present state of DCT ...
Post a Comment
Read more

Home Remedy for Malnourished Kids Works Wonders Case Report-Crimson Publishers

Home Remedy for Malnourished Kids Works Wonders Case Report- Crimson Publishers Ashish Satav* Head Administration, India *Corresponding author:  Ashish Satav, Head Administration, India, Tel: 91-9423118877; Email: Submission:  July 13, 2018;  Published:  September 10, 2018 Many severely malnourished (grade IV) children continue todie every year in Melghat because their parents are unwilling to hospitalize them. Myths and mis-beliefs too hold them back from approaching the hospital. However, doctors from MAHAN Trustworking in the tribal belt have proved that these children can bealso saved through home or community based treatment, bothmedical and dietary. Successful treatment of Lakshmi SukhramJamunkar, a 23-month-old girl whose condition was worse than agrade IV child, is a shining example. She was treated at her homeunder the supervision of an illiterate but well-trained village healthworker, Meerabai. Lakshmi‘s case s...
Post a Comment
Read more